Abstract: Extended-release microsphere formulations comprising lurasidone are provided. In one aspect. the microsphere formulations are characterized in that the lurasidone is released in vivo in humans over a period of about 30 days or about 60 days. Methods for making and using the formulations are also provided.

Abstract: The present invention relates to stable and low viscosity liquid pharmaceutical compositions comprising antibodies binding to human alpha synuclein and to methods for use of antibodies binding to human alpha synuclein for treating synucleinopathies or prodromal synucleinopathy, incl. suitable doses and/or dosing regimens. These antibodies for use in treatment of synucleinopathies or prodromal synucleinopathy may be formulated in the stable and low viscosity liquid pharmaceutical compositions of the invention.

Abstract: The present invention related to an apparatus and method for the manufacturing of beverage capsules. The apparatus can preheat the material used to form the beverage material during the manufacturing process. The material and apparatus are particularly suitable for use in producing single serve beverage capsules from biodegradable materials.

Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.

Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.

Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable media for 3D radar weather data rendering techniques. A computer-implemented method for 3D radar weather data rendering includes retrieving weather data from a weather radar. Gridded data is generated based on the weather data. The gridded data includes a uniform grid of cubes, where each of the cubes is associated with at least one weather parameter value of a plurality of weather parameter values corresponding to the weather data. A triangular mesh for a data grouping within the gridded data is extracted. An object file including vertices and faces associated with the triangular mesh is generated. The object file is communicated to a three-dimensional (3D) visualization system to present a 3D rendering of the object file.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Abstract: Some embodiments provided herein relate to methods and pharmaceutical compositions comprising recombinant human surfactant protein D or active fragments thereof. Some such embodiments include solutions or suspensions, and lyophilized solid forms of recombinant human surfactant protein D or active fragments thereof.

Abstract: The present invention related to an apparatus and method for the manufacturing of beverage capsules. The apparatus can preheat the material used to form the beverage material during the manufacturing process. The material and apparatus are particularly suitable for use in producing single serve beverage capsules from biodegradable materials.

Abstract: Some embodiments of the methods and compositions provided herein include identifying and/or quantifying oligomeric species of surfactant protein-D (SP-D). Some embodiments include performing an asymmetric flow field-flow fractionation with multi-angle laser light scattering (AF4-MALLS) analysis on the SP-D.

Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable media for 3D radar weather data rendering techniques. A computer-implemented method for 3D radar weather data rendering includes retrieving weather data from a weather radar. Gridded data is generated based on the weather data. The gridded data includes a uniform grid of cubes, where each of the cubes is associated with at least one weather parameter value of a plurality of weather parameter values corresponding to the weather data. A triangular mesh for a data grouping within the gridded data is extracted. An object file including vertices and faces associated with the triangular mesh is generated. The object file is communicated to a three-dimensional (3D) visualization system to present a 3D rendering of the object file.

Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Abstract: Disclosed in some examples are methods, systems, devices, and machine-readable mediums for augmented reality (AR) Doppler weather radar (DWR) visualization application. A method is disclosed that includes retrieving weather radar data from a weather radar. The method may further include generating two (2) dimensional (D) polygons from the weather radar data, wherein the weather data comprises a three (3) D coordinate and a value indicating a weather condition, and wherein the 2D polygons are generated based on values of the value indicating the weather condition and an area of coverage. The method may further include sending the 2D polygons to an augmented-reality (AR) weather radar visualization system for the AR weather radar system to present a 3D rendering of the 2D polygons. The method may provide real-time weather 3D radar data that is animated.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficienty are disclosed.

Abstract: Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed.

Abstract: The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.